These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 20808831)
1. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer. Chen J; Gomes AR; Monteiro LJ; Wong SY; Wu LH; Ng TT; Karadedou CT; Millour J; Ip YC; Cheung YN; Sunters A; Chan KY; Lam EW; Khoo US PLoS One; 2010 Aug; 5(8):e12293. PubMed ID: 20808831 [TBL] [Abstract][Full Text] [Related]
2. The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression. Hui RC; Gomes AR; Constantinidou D; Costa JR; Karadedou CT; Fernandez de Mattos S; Wymann MP; Brosens JJ; Schulze A; Lam EW Mol Cell Biol; 2008 Oct; 28(19):5886-98. PubMed ID: 18644865 [TBL] [Abstract][Full Text] [Related]
3. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway. Li A; Wang J; Wu M; Zhang X; Zhang H Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin. Ho KK; McGuire VA; Koo CY; Muir KW; de Olano N; Maifoshie E; Kelly DJ; McGovern UB; Monteiro LJ; Gomes AR; Nebreda AR; Campbell DG; Arthur JS; Lam EW J Biol Chem; 2012 Jan; 287(2):1545-55. PubMed ID: 22128155 [TBL] [Abstract][Full Text] [Related]
5. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice. Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Sunters A; Madureira PA; Pomeranz KM; Aubert M; Brosens JJ; Cook SJ; Burgering BM; Coombes RC; Lam EW Cancer Res; 2006 Jan; 66(1):212-20. PubMed ID: 16397234 [TBL] [Abstract][Full Text] [Related]
7. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Li S; Zhou Y; Wang R; Zhang H; Dong Y; Ip C Mol Cancer Ther; 2007 Mar; 6(3):1031-8. PubMed ID: 17339365 [TBL] [Abstract][Full Text] [Related]
8. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo. Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256 [TBL] [Abstract][Full Text] [Related]
9. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells. Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235 [TBL] [Abstract][Full Text] [Related]
10. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy. Fang L; Wang H; Zhou L; Yu D Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483 [TBL] [Abstract][Full Text] [Related]
11. Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells. Taylor JR; Lehmann BD; Chappell WH; Abrams SL; Steelman LS; McCubrey JA Oncotarget; 2011 Aug; 2(8):610-26. PubMed ID: 21881167 [TBL] [Abstract][Full Text] [Related]
13. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163 [TBL] [Abstract][Full Text] [Related]
14. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells. Liu H; Yin J; Wang C; Gu Y; Deng M; He Z Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium. Fujiki K; Inamura H; Matsuoka M Arch Toxicol; 2013 Dec; 87(12):2119-27. PubMed ID: 23673518 [TBL] [Abstract][Full Text] [Related]
16. FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma. Santo EE; Stroeken P; Sluis PV; Koster J; Versteeg R; Westerhout EM Cancer Res; 2013 Apr; 73(7):2189-98. PubMed ID: 23378341 [TBL] [Abstract][Full Text] [Related]
17. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Habashy HO; Rakha EA; Aleskandarany M; Ahmed MA; Green AR; Ellis IO; Powe DG Breast Cancer Res Treat; 2011 Aug; 129(1):11-21. PubMed ID: 21336599 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691 [TBL] [Abstract][Full Text] [Related]
19. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways. Ock CW; Kim GD Molecules; 2021 Nov; 26(21):. PubMed ID: 34771123 [TBL] [Abstract][Full Text] [Related]
20. Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells. Hui RC; Francis RE; Guest SK; Costa JR; Gomes AR; Myatt SS; Brosens JJ; Lam EW Mol Cancer Ther; 2008 Mar; 7(3):670-8. PubMed ID: 18347152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]